Key clinical point: Despite starting a statin or antihypertensive drug, people can regress on other cardiovascular disease risks factors like body mass and inactivity.
Major finding: Nonobese people starting statin or antihypertensive treatment had a 82% higher incidence of obesity than those not starting these drugs.
Study details: A review of prospectively collected data from 41,225 adults in the Finnish Public Sector Study.
Disclosures: The study received no commercial funding. Dr. Korhonen had no disclosures.
Korhonen MJ et al. J Am Heart Assoc. 2020 Feb 5. doi: 10.1161/JAHA.119.014.168.